Acute Gout Management with Combination Therapy

Introduction to Combination Therapy

The American College of Rheumatology recommends combination therapy with diclofenac and colchicine for acute gout, particularly in severe attacks involving multiple large joints or polyarticular arthritis, in patients with adequate renal function and no gastrointestinal contraindications 1, 2

For patients with severe renal impairment, the European League Against Rheumatism recommends avoiding the combination of colchicine and NSAIDs, and instead using oral prednisone 30-35 mg daily for 3-5 days as first-line therapy 3, 2
In patients with mild-to-moderate renal impairment, the combination can be used with dose adjustment and close monitoring, with reduced colchicine dose and monitoring for neurotoxicity and muscular toxicity 3, 4
For patients with normal renal function, combination therapy is appropriate for severe attacks, using standard dosing of colchicine and diclofenac 1, 3

The American College of Rheumatology advises against using colchicine in combination with strong CYP3A4 inhibitors or strong P-glycoprotein inhibitors, and instead recommends using prednisone 3, 4
Patients on statins should be monitored for increased risk of neurotoxicity and muscular toxicity with colchicine 3, 4

The European League Against Rheumatism recommends colchicine dosing of 1.2 mg at first sign of flare, followed by 0.6 mg once or twice daily until attack resolves, and diclofenac dosing of full anti-inflammatory dose for 5-10 days 3, 2
A proton pump inhibitor should be added if any gastrointestinal risk factors are present 3, 4
Close monitoring is necessary for gastrointestinal bleeding, diarrhea, muscle pain or weakness, and worsening renal function 3, 4

For patients with both renal impairment and gastrointestinal history, the American College of Rheumatology recommends prednisone 30-35 mg daily for 3-5 days as the safest and most appropriate choice, avoiding the risks of both colchicine and NSAIDs 3, 2

The European League Against Rheumatism advises against combining NSAIDs with systemic corticosteroids due to synergistic gastrointestinal toxicity risk 1
The American College of Rheumatology recommends avoiding high-dose hourly colchicine regimens due to excessive toxicity with no additional benefit 2
Combination therapy should not be used without assessing renal function first, as severe renal impairment is an absolute contraindication to both agents 3, 4